[ad_1]
FDA reveals AstraZeneca to have applied for COVID 19 vaccine registration in Thailand. The Director General of the Department of Disease Control revealed that the FDA will allow emergency vaccines this week.
On January 18, 2021, the Thai news agency reported that Dr. Opasakarn Kawinpong Director General, Department of Disease Control Citing progress in registering the COVID-19 vaccine, the FDA will allow emergency vaccination this week. That will be in line with the vaccination from the end of February. But the details are requested to wait for the FDA.
Dr. Opas said that in COVID-19 vaccination adverse reactions will be followed up to 4 weeks after vaccination, with the effects they may or may not have. Or risk There should be a committee of experts to consider this matter. If death is required, an autopsy is required. However, vaccination is voluntary. There are currently some polls. The vaccine to be administered is not related to the affected vaccine. Or there are many side effects that are some of the most criticized We do not order Not registered in Thailand.
Images from Lutsenko_Oleksandr / Shutterstock.com.
While Dr. Surachok Tangwiwat, Deputy Secretary General of the FDA, said that the company Astra Seneca COVID-19 vaccine manufacturers abroad have submitted documents for the registration of vaccines in Thailand with the FDA, with a quality statement, production and production process. To be sold in Thailand Once approved, it will expedite the registration of AstraZeneca vaccines in Thailand. The vaccine is not related to 26 million doses of vaccines manufactured in Thailand.
>> Read the information and follow the COVID 19 situation << here.
Thanks to information from
[ad_2]
